These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia. Brennan L; Narendran A Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487 [TBL] [Abstract][Full Text] [Related]
29. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828 [TBL] [Abstract][Full Text] [Related]
30. Targeting chemokines for acute lymphoblastic leukemia therapy. Hong Z; Wei Z; Xie T; Fu L; Sun J; Zhou F; Jamal M; Zhang Q; Shao L J Hematol Oncol; 2021 Mar; 14(1):48. PubMed ID: 33743810 [TBL] [Abstract][Full Text] [Related]
31. Clinical and cellular pharmacology in relation to solid tumours of childhood. Estlin EJ; Veal GJ Cancer Treat Rev; 2003 Aug; 29(4):253-73. PubMed ID: 12927566 [TBL] [Abstract][Full Text] [Related]
33. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299 [TBL] [Abstract][Full Text] [Related]
34. Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving concepts. Ottmann OG; Wassmann B Best Pract Res Clin Haematol; 2002 Dec; 15(4):757-69. PubMed ID: 12617875 [TBL] [Abstract][Full Text] [Related]
35. Use of L-asparaginase in childhood ALL. Müller HJ; Boos J Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345 [TBL] [Abstract][Full Text] [Related]
36. Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab. Sutton R; Pozza LD; Khaw SL; Fraser C; Revesz T; Chamberlain J; Mitchell R; Trahair TN; Bateman CM; Venn NC; Law T; Ong E; Heatley SL; McClure BJ; Meyer C; Marschalek R; Henderson MJ; Cross S; White DL; Kotecha RS Pediatr Blood Cancer; 2021 May; 68(5):e28922. PubMed ID: 33638292 [TBL] [Abstract][Full Text] [Related]
37. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood. Bertaina A; Vinti L; Strocchio L; Gaspari S; Caruso R; Algeri M; Coletti V; Gurnari C; Romano M; Cefalo MG; Girardi K; Trevisan V; Bertaina V; Merli P; Locatelli F Br J Haematol; 2017 Feb; 176(4):629-636. PubMed ID: 28116786 [TBL] [Abstract][Full Text] [Related]
38. The changing landscape of treatment options in childhood acute lymphoblastic leukaemia. Micallef B; Nisticò R; Sarac SB; Bjerrum OW; Butler D; Sammut Bartolo N; Serracino-Inglott A; Borg JJ Drug Discov Today; 2022 May; 27(5):1483-1494. PubMed ID: 35007767 [TBL] [Abstract][Full Text] [Related]
39. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S; Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289 [TBL] [Abstract][Full Text] [Related]